JCEM:乳腺癌幸存者更年期来了怎么办?

2017-08-03 xuyihan MedSci原创

全球约930万乳腺癌幸存者面临由于雌激素缺乏导致的相关症状与临床问题--睡眠障碍、外阴阴道萎缩(VVA)、血管舒缩症状(VMS)、情绪变化、抑郁症状、心血管疾病、骨质疏松等等。

全球约930万乳腺癌幸存者面临由于雌激素缺乏导致的相关症状与临床问题--睡眠障碍、外阴阴道萎缩(VVA)、血管舒缩症状(VMS)、情绪变化、抑郁症状、心血管疾病、骨质疏松等等。

2017年8月2日在JCEM上发表的一篇文章在审查了指导乳腺癌幸存者更年期症状管理的证据--随机对照临床试验、观察性研究、循证威廉亚洲博彩公司 和专业协会的专家意见之后,提出了相应的建议,可为乳腺癌幸存者带来福音。

乳腺癌之后,女性一般不予绝经后激素替代或替勃龙治疗,而应优化生活方式。有中至重度症状的女性可能从思想-大脑-行为或非激素药物治疗获益。选择性5-羟色胺/去甲肾上腺素再摄取抑制剂和gabapentenoid对VMS和生活质量有良好效果。对于骨质疏松,非激素药物是可用的。VVA治疗仍待解决。低剂量阴道雌激素被少量吸收而血液中水平维持在正常范围内,但可能刺激隐性乳腺癌细胞,尽管研究不充分,但也不建议,尤其是芳香酶抑制剂。阴道内DHEA和口服ospemiphene已被批准用于治疗乳腺癌术后性交困难,这也是VVA的症状之一。阴道激光治疗也用于VVA,但缺乏对照研究的结果。而目前在发展可能成为未来治疗的包括拉索昔芬、神经激肽B抑制剂、星状神经节阻滞、阴道睾酮和雌四醇。

由此可见,各种非激素的选择和治疗可用于治疗乳腺癌后雌激素耗竭所致的症状和临床问题。当然更重要的是个体化的治疗方案。

原始出处:


本文系williamhill asia 医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2063019, encodeId=4216206301969, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sat Nov 04 18:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777637, encodeId=ab0e1e77637ba, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Thu Nov 16 00:17:00 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230521, encodeId=ef93230521aa, content=对于骨质疏松,非激素药物是可用的。VVA治疗仍待解决。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Aug 06 00:59:28 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230514, encodeId=ce3f23051420, content=外阴阴道萎缩(VVA)、血管舒缩症状(VMS), beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Aug 06 00:54:29 CST 2017, time=2017-08-06, status=1, ipAttribution=)]
    2017-11-04 achengzhao
  2. [GetPortalCommentsPageByObjectIdResponse(id=2063019, encodeId=4216206301969, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sat Nov 04 18:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777637, encodeId=ab0e1e77637ba, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Thu Nov 16 00:17:00 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230521, encodeId=ef93230521aa, content=对于骨质疏松,非激素药物是可用的。VVA治疗仍待解决。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Aug 06 00:59:28 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230514, encodeId=ce3f23051420, content=外阴阴道萎缩(VVA)、血管舒缩症状(VMS), beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Aug 06 00:54:29 CST 2017, time=2017-08-06, status=1, ipAttribution=)]
    2017-11-16 smallant2015
  3. [GetPortalCommentsPageByObjectIdResponse(id=2063019, encodeId=4216206301969, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sat Nov 04 18:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777637, encodeId=ab0e1e77637ba, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Thu Nov 16 00:17:00 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230521, encodeId=ef93230521aa, content=对于骨质疏松,非激素药物是可用的。VVA治疗仍待解决。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Aug 06 00:59:28 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230514, encodeId=ce3f23051420, content=外阴阴道萎缩(VVA)、血管舒缩症状(VMS), beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Aug 06 00:54:29 CST 2017, time=2017-08-06, status=1, ipAttribution=)]
    2017-08-06 随梦飞扬

    对于骨质疏松,非激素药物是可用的。VVA治疗仍待解决。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2063019, encodeId=4216206301969, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sat Nov 04 18:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777637, encodeId=ab0e1e77637ba, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Thu Nov 16 00:17:00 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230521, encodeId=ef93230521aa, content=对于骨质疏松,非激素药物是可用的。VVA治疗仍待解决。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Aug 06 00:59:28 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230514, encodeId=ce3f23051420, content=外阴阴道萎缩(VVA)、血管舒缩症状(VMS), beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Aug 06 00:54:29 CST 2017, time=2017-08-06, status=1, ipAttribution=)]
    2017-08-06 随梦飞扬

    外阴阴道萎缩(VVA)、血管舒缩症状(VMS)

    0

相关威廉亚洲官网

JAMA:细胞毒性肿瘤浸润淋巴细胞在转移性HER2阳性乳腺癌预后预测中的作用

目前已经有越来越多的证据表明,肿瘤浸润淋巴细胞(TILs)与临床结局有关,可预测化疗和人表皮生长因子受体2(HER2,有ERBB2基因编码)靶向治疗在HER2阳性乳腺癌患者中的疗效。为了进一步研究TILs,特别是细胞毒性CD8+T细胞在预测HER2阳性转移性乳腺癌患者临床结局中的作用,JAMA上近日发表的文章报道了相关结果。

Lancet:早期乳腺癌术后局部放疗效果优于全乳放疗

研究认为,对于早期乳腺癌患者,保乳手术后的减量或部分放疗效果优于标准的全乳放疗且副作用更为温和

JCO:钼靶检查在老年乳腺癌幸存者中使用如何?

众所周知乳腺钼靶检查已成为乳腺癌普查和监测的重要方式,然而对寿命有限的老年乳腺癌幸存者每年钼靶监测的好处尚不清楚,也存在着相当的风险;然而在这些妇女中钼靶检查的使用却知之甚少。

JCO:不同亚型乳腺癌保乳术后放疗反应如何?

2017年7月31日在JCO上发表的一篇文章评估了不同亚型的乳腺癌在保乳手术后予以辅助放疗(RT)的效果,并进行了大的随机临床试验的长期随访。

JCEM:妊娠末期雌激素水平与母体乳腺癌关系如何?

大家知道足月妊娠可使母亲乳腺癌风险短暂增加但终生减少么?在妊娠末3个月雌酮(E1)、雌二醇(E2)、雌三醇(E3)是高浓度的雌激素。E1和E2的代谢产物产生致癌中介,而E3却不会。近日在JCEM上发表的一篇文章验证怀孕期间高浓度E3起保护作用而高浓度E1+E2增加风险的假设。

JAMA Oncology:哪种患者可从曲妥珠单抗vs拉帕替尼中获益最多?

早期HER2阳性乳腺癌患者中,肿瘤浸润淋巴细胞的计数水平可预测曲妥珠单抗vs拉帕替尼治疗的有效性。然而,在转移性疾病患者中,该计数是否仍可预测哪种患者可从曲妥珠单抗vs拉帕替尼的治疗中获益最多?7月27日在线发表于《JAMA Oncology》上,一项由加拿大英属哥伦比亚大学遗传病理评价中心的Torsten O. Nielsen博士进行的研究显示,该计数的预测价值仍然有效。